Nicox Plots US Submission After Another Phase III Glaucoma Win

 
• By Kevin Grogan
  
Santen applied for sepetaprost's global first approval in Japan for glaucoma.
• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Ophthalmology

More from Sensory